Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
WALD
#3051
Waldencast plc Class A Ordinary Share
1.6
9
0.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
0.00%
Monatliche Änderung
+4.97%
6 month change
+3.05%
Jahresänderung
-45.83%
Vorheriger Schlusskurs
1.6
9
Open
1.6
9
Bid
Ask
Low
1.6
9
High
1.6
9
Volumen
41
Märkte
Aktien
Technologie
WALD
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
112.03 M
—
Valuation ratios
Enterprise value
1.53 B
—
Price to earnings ratio
-10.31
—
Price to sales ratio
—
—
Price to cash flow ratio
49.82
—
Price to book ratio
0.66
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
0.06
0.29
Return on equity %
0.07
0.33
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
0.66
—
Current ratio
1.35
5.02
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
0.14
0.44
Long term debt to total equity ratio
0.21
0.67
Per share metrics
Operating cash flow per share
0.54
4.95
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
0.14
0.43
Net current asset value per share
0.95
3.13
Tangible book value per share
-1.77
-6.85
Working capital per share
0.24
0.97
Book value per share
6.06
22.31
Nachrichten
Obagi Medical gewinnt DermFx als Partner für Hyaluronsäure-Programm
Obagi Medical names DermFx as partner for hyaluronic acid program
Obagi Medical partners with Next Health for filler evaluation program
Obagi Medical: Alpha Aesthetics Partners wird erster Partner für neues Hyaluron-Filler-Programm
Alpha Aesthetics Partners joins Obagi’s ALOHA program for HA filler
Waldencast terminiert Hauptversammlung und strukturiert Verwaltungsrat neu
Waldencast schedules annual meeting and announces board changes
Waldencast Acquisition: EPS verfehlt Schätzungen um 0,03 $ - Umsatz schlechter als erwartet
Waldencast Acquisition earnings missed by $0.03, revenue fell short of estimates
Canaccord Genuity senkt Kursziel für Waldencast wegen schwacher Umsätze
Canaccord Genuity lowers Waldencast stock price target on weak sales
Jefferies lowers Waldencast stock price target to $3.50 on weak sales